Innovator Spotlight

Harnessing Viruses to Help the Body Beat Cancer Dr. Robert Coffin, inventor of Amgen’s IMLYGIC, will be one of the honorees for Inventor of the Year at the IPO Education Foundation’s Annual Awards Dinner in Washington, DC on 6 December.

How BLINCYTO Is Taking a BiTE ® Out of Cancer Amgen’s BLINCYTO is a prescription medicine used to treat a certain type of acute lymphoblastic leukemia (ALL)—a cancer of the blood in which a particular kind of white blood cell

A Cancer Fighting Combination Two of the six drugs on the list of IPOEF’s 2016 Inventor of the Year Award winners are Bristol-Myers Squibb’s (BMS’s) OPDIVO and YERVOY, which are approved both individually and in combination by the U.S. Food

One Drug That Might Hold the “Key” to Multiple Cancers The 2016 IPO Education Foundation’s Inventor of the Year Award will honor six life-saving cancer immunotherapies at its Annual Foundation Awards Dinner in Washington, D.C. on 6 December 2016. One

A Breakthrough Treatment with Broad Implications As the representative inventor on one of the six cancer immunotherapy treatments being honored for the 2016 IPO Education Foundation’s Inventor of the Year Award, Yan Wu of Genentech and her team are helping

Barbara Fisher, Assistant General Counsel, Intellectual Property at Lockheed Martin and a member of the IPO Board of Directors, spearheaded the formation of IPO’s Women in IP Committee and has been a longtime advocate for promoting women in STEM, both